Prefilled syringe eliminates the need to reconstitute separate vials prior to administration and simplifies the vaccine ...

The retrospective cohort study included more than 130,000 people in the US. It reveals that the shingles vaccine (called ...

The US Food and Drug Administration (FDA) has approved GSK's Shingrix vaccine (recombinant zoster vaccine or RZV) in a ...

This new Shingrix vaccine presentation eliminates the need for reconstitution, simplifying the administration process for ...

Shingrix has been administered in a two-step process. It involved combining two separate vials—a freeze-dried (lyophilized) powder containing the antigen, and a liquid adjuvant, by trained healthcare ...

A recent study suggests that certain immunizations may unexpectedly protect against cognitive decline, potentially reducing ...

The Food and Drug Administration (FDA) has approved a new prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted).

Patients with inflammatory arthritis would benefit from vaccination against herpes zoster, with the Shingrix vaccine showing a crude effectiveness of 50%.

Shingrix's manufacturer, GlaxoSmithKline, didn't anticipate it would be so popular when it first hit the market. In the first six months of 2018 alone, more doses of Shingrix were administered in ...

The cash will fund a phase 2b trial in 678 people aged over 50 that will compare CRV‑101's immunogenicity and safety profile relative to Shingrix, according to Curevo.

The FDA has approved a prefilled syringe option of Shingrix which will streamline administration of GSK’s herpes zoster ...